These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 28042958)

  • 21. (18)F-Fluorodeoxyglucose positron emission tomography ((18)F-FDG PET) for the early detection of response to neoadjuvant chemotherapy for locally advanced rectal cancer.
    Nishimura J; Hasegawa J; Ogawa Y; Miwa H; Uemura M; Haraguchi N; Hata T; Yamamoto H; Takemasa I; Mizushima T; Nezu R; Doki Y; Mori M
    Surg Today; 2016 Oct; 46(10):1152-8. PubMed ID: 26711129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MR imaging perfusion and diffusion analysis to assess preoperative Short Course Radiotherapy response in locally advanced rectal cancer: Standardized Index of Shape by DCE-MRI and intravoxel incoherent motion-derived parameters by DW-MRI.
    Petrillo A; Fusco R; Granata V; Setola SV; Sansone M; Rega D; Delrio P; Bianco F; Romano GM; Tatangelo F; Avallone A; Pecori B
    Med Oncol; 2017 Nov; 34(12):198. PubMed ID: 29151142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of the standardized index of shape tool to analyze DCE-MRI data in the assessment of neo-adjuvant therapy in locally advanced rectal cancer.
    Fusco R; Granata V; Sansone M; Rega D; Delrio P; Tatangelo F; Romano C; Avallone A; Pupo D; Giordano M; Grassi R; Ravo V; Pecori B; Petrillo A
    Radiol Med; 2021 Aug; 126(8):1044-1054. PubMed ID: 34041663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The value of 18F-FDG PET/CT for assessing the response to neoadjuvant therapy in locally advanced rectal cancer.
    Murcia Duréndez MJ; Frutos Esteban L; Luján J; Frutos MD; Valero G; Navarro Fernández JL; Mohamed Salem L; Ruiz Merino G; Claver Valderas MA
    Eur J Nucl Med Mol Imaging; 2013 Jan; 40(1):91-7. PubMed ID: 23081822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accuracy of F-18 FDG PET/CT with optimal cut-offs of maximum standardized uptake value according to size for diagnosis of regional lymph node metastasis in patients with rectal cancer.
    Bae SU; Won KS; Song BI; Jeong WK; Baek SK; Kim HW
    Cancer Imaging; 2018 Sep; 18(1):32. PubMed ID: 30217167
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Avallone A; Aloj L; Pecori B; Caracò C; De Stefano A; Tatangelo F; Silvestro L; Granata V; Bianco F; Romano C; Di Gennaro F; Budillon A; Petrillo A; Muto P; Botti G; Delrio P; Lastoria S
    J Nucl Med; 2019 Nov; 60(11):1560-1568. PubMed ID: 30877175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic value of FDG-PET/CT for lateral pelvic lymph node metastasis in rectal cancer treated with preoperative chemoradiotherapy.
    Ishihara S; Kawai K; Tanaka T; Kiyomatsu T; Hata K; Nozawa H; Morikawa T; Watanabe T
    Tech Coloproctol; 2018 May; 22(5):347-354. PubMed ID: 29623475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
    Birlik B; Obuz F; Elibol FD; Celik AO; Sokmen S; Terzi C; Sagol O; Sarioglu S; Gorken I; Oztop I
    Magn Reson Imaging; 2015 Feb; 33(2):201-12. PubMed ID: 25460330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MRI T2-weighted sequences-based texture analysis (TA) as a predictor of response to neoadjuvant chemo-radiotherapy (nCRT) in patients with locally advanced rectal cancer (LARC).
    Crimì F; Capelli G; Spolverato G; Bao QR; Florio A; Milite Rossi S; Cecchin D; Albertoni L; Campi C; Pucciarelli S; Stramare R
    Radiol Med; 2020 Dec; 125(12):1216-1224. PubMed ID: 32410063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Individualized threshold for tumor segmentation in 18F-FDG PET/CT imaging: The key for response evaluation of neoadjuvant chemoradiation therapy in patients with rectal cancer?
    Fagundes TC; Mafra A; Silva RG; Castro ACG; Silva LC; Aguiar PT; Silva JA; P Junior E; Machado AM; Mamede M
    Rev Assoc Med Bras (1992); 2018 Feb; 64(2):119-126. PubMed ID: 29641665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FDG-avid presacral soft tissue mass in previously treated rectal cancer: Diagnostic outcome and additional value of MRI, including diffusion-weighted imaging.
    Pennings JP; de Haas RJ; Murshid KJA; de Jong KP; Dierckx RAJO; Kwee TC
    Eur J Surg Oncol; 2019 Apr; 45(4):606-612. PubMed ID: 30594404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of response to neoadjuvant radiotherapy in patients with locally advanced rectal cancer by means of sequential 18FDG-PET.
    Everaert H; Hoorens A; Vanhove C; Sermeus A; Ceulemans G; Engels B; Vermeersch M; Verellen D; Urbain D; Storme G; De Ridder M
    Int J Radiat Oncol Biol Phys; 2011 May; 80(1):91-6. PubMed ID: 20605358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is the standardized uptake value of FDG-PET/CT predictive of pathological complete response in locally advanced rectal cancer treated with capecitabine-based neoadjuvant chemoradiation?
    Bampo C; Alessi A; Fantini S; Bertarelli G; de Braud F; Bombardieri E; Valvo F; Crippa F; Di Bartolomeo M; Mariani L; Milione M; Biondani P; Avuzzi B; Chiruzzi C; Pietrantonio F
    Oncology; 2013; 84(4):191-9. PubMed ID: 23328390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The efficiency of
    Uemura M; Ikeda M; Handa R; Danno K; Nishimura J; Hata T; Takemasa I; Mizushima T; Yamamoto H; Sekimoto M; Doki Y; Eguchi H
    BMC Cancer; 2021 Oct; 21(1):1132. PubMed ID: 34674666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Value of combined multiparametric MRI and FDG-PET/CT to identify well-responding rectal cancer patients before the start of neoadjuvant chemoradiation.
    Schurink NW; Min LA; Berbee M; van Elmpt W; van Griethuysen JJM; Bakers FCH; Roberti S; van Kranen SR; Lahaye MJ; Maas M; Beets GL; Beets-Tan RGH; Lambregts DMJ
    Eur Radiol; 2020 May; 30(5):2945-2954. PubMed ID: 32034488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The predictive value of 18F-FDG PET/CT for assessing pathological response and survival in locally advanced rectal cancer after neoadjuvant radiochemotherapy.
    Leccisotti L; Gambacorta MA; de Waure C; Stefanelli A; Barbaro B; Vecchio FM; Coco C; Persiani R; Crucitti A; Tortorelli AP; Giordano A; Valentini V
    Eur J Nucl Med Mol Imaging; 2015 Apr; 42(5):657-66. PubMed ID: 25687534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined use of 18F-FDG PET/CT, DW-MRI, and DCE-MRI in treatment response for preoperative chemoradiation therapy in locally invasive rectal cancers.
    Gu J; Khong PL; Wang S; Law W; Chan T; Shek TW; Liu R; Zhang J
    Clin Nucl Med; 2013 May; 38(5):e226-9. PubMed ID: 23235482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. To determine the utility of fluorodeoxyglucose-positron emission tomography-computed tomography scan in predicting pathological response in operated carcinoma rectum patients after initial neoadjuvant chemoradiation.
    Sharma N; Takkar P; Purkayastha A; Singh BK
    J Cancer Res Ther; 2019; 15(1):9-14. PubMed ID: 30880747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Semiquantitative Volumetry by Sequential PET/CT May Improve Prediction of Complete Response to Neoadjuvant Chemoradiation in Patients With Distal Rectal Cancer.
    Dos Anjos DA; Perez RO; Habr-Gama A; São Julião GP; Vailati BB; Fernandez LM; de Sousa JB; Buchpiguel CA
    Dis Colon Rectum; 2016 Sep; 59(9):805-12. PubMed ID: 27505108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of metabolic response with
    Segreto S; Fonti R; Ottaviano M; Pellegrino S; Pace L; Damiano V; Palmieri G; Del Vecchio S
    Cancer Imaging; 2017 Mar; 17(1):10. PubMed ID: 28264726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.